Evicenter
MarkdownMedical informationP&T meetings
Lonimecgene renparvovec (TSHA-102)

Rett syndrome

Launch
Not announced
Last updated
199 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology

Prevalence of Rett syndrome

9 evidence topics · 12 sources

Global pooled prevalence in females: systematic review and meta-analysis

“We conducted a search of PubMed, Embase, Web of Science, Cochrane Library, LILACS, and LIVIVO to retrieve studies published in English between Jan. 1, 2000, and June 30, 2021. Pooled prevalence with a 95% confidence interval (CI) was estimated using a random-effects meta-analysis based on a generalized linear mixed model with a logit link.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Ten eligible studies were identified (all in females), with a combined sample size of 9.57 million women and 673 Rett syndrome cases. The pooled prevalence estimate (random effects) was 7.1 per 100,000 females (95% CI: 4.8, 10.5, heterogeneity p < 0.001). Despite greatly variable precision of estimation, all estimates were compatible with a prevalence range of approximately 5 to 10 cases per 100,000 females based on their respective 95% CIs.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Study-specific prevalence estimates per 100,000 females (95% CI) ranged from 0.0 (0.0, 8.8) to 38.3 (4.6, 138.0), with a highly significant heterogeneity test (p < 0.001, I2 = 0.831).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“No studies that included patients with RTT older than 35 years were included.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote